Agfa HealthCare Signs Over 40 New ORBIS Agreements

Article of the Month!

Agfa HealthCareAgfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, has signed over 40 new agreements for its leading Hospital/Clinical Information System ORBIS since January 2009. ORBIS, available in Germany, Austria, Switzerland, France, Belgium and Luxembourg is a hospital-wide IT solution which manages and monitors all patient-oriented processes: medical, nursing, administrative and business.

ORBIS is an enterprise-wide solution designed to enhance the quality of patient care and provides fast and complete availability of patients' histories, including all images and clinical and administrative data. The permanent availability of this information to authorized nursing, technical and medical staff, enables quicker diagnoses and treatments. ORBIS is designed to help care facilities increase productivity, improve the delivery of care and save cost.

New agreements for ORBIS in 2009 include local, regional and university care and hospital centers. In France agreements were recently signed with the Centre Hospitalier Universitaire du Mans, the Centre Hospitalier Universitaire de Montpellier, and the Centre Hospitalier Intercommunal de Créteil. In Belgium and Luxembourg, the ZOL Genk hospital and St. Lucas hospital in Ghent have begun implementation of the new system, and agreements were signed with the Centre Hospitalier Emilie Mayrisch in Luxembourg. New agreements with leading care facilities in Germany, Austria and Switzerland include the St. Theresien Hospital in Mannheim (Germany), the SLK group in Heilbronn (Germany), the Hera nursing home in Vienna (Austria) and the Appenzell Hospital in Appenzell (Switzerland).

Agfa HealthCare has also signed several major agreements for its ORBIS Document Management System, also known as HYDMedia, such as with the University Hospital of Leipzig in Germany.

"Agfa HealthCare's IT Division has continued to successfully achieve its planned growth in 2009 and has, as a result, re-enforced its leading European HIS/CIS position in the market. The success of the solution is, in part, based on our continued drive to deliver new and innovative solutions for ORBIS, including new clinical applications and the interface certification by SAP," states Dr. Volker Wetekam, Vice President IT Division, Agfa HealthCare. "We look forward to a successful full year result for ORBIS and further growth in the years to come."

Today some 850 customers in Europe work with ORBIS, totaling over 500,000 users which include clinicians, nurses, hospital management, administrative and technical staff.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and specific industrial applications (Agfa Materials). Agfa's headquarters are in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,032 million Euro in 2008.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2008 were 1,223 million Euro.

For more information on Agfa HealthCare, please visit www.agfa.com/healthcare.

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...

Oracle Purchase of Cerner Approved

Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is a leading provider of digital...